版本:
中国

BRIEF-TherapeuticsMD's NDA for Yuvvexy accepted by FDA

Sept 19 TherapeuticsMD Inc :

* Announces FDA acceptance of new drug application (NDA) and prescription drug user fee act (PDUFA) date for Yuvvexy(TM)(TX-004HR)

* TherapeuticsMD says PDUFA target action date of May 7, 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐